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Abstract: This work presents the effects of feruloylated oligosaccharides (FOs) of rice 
bran on murine bone marrow-derived dendritic cells (BMDCs) and the potential pathway 
through which the effects are mediated. We found that FOs induced phenotypic maturation 
of DCs, as shown by the increased expression of CD40, CD80/CD86 and MHC-I/II molecules. 
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FOs efficiently induced maturation of DCs generated from C3H/HeN or C57BL/6 mice 
with normal toll-like receptor 4 (TLR-4) or TLR-2 but not DCs from mice with mutated 
TLR4 or TLR2. The mechanism of action of FOs may be mediated by increased 
phosphorylation of ERK, p38 and JNK mitogen-activated protein kinase (MAPKs) and 
increased NF-B activity, which are important signaling molecules downstream of TLR-4 
and TLR-2. These data suggest that FOs induce DCs maturation through TLR-4 and/or 
TLR-2 and that FOs might have potential efficacy against tumor or virus infection or 
represent a candidate-adjuvant approach for application in immunotherapy and vaccination. 
Keywords: dendritic cells; feruloylated oligosaccharides; maturation; rice bran;  
Toll-like receptor (TLR) 
 
Abbreviations: FOs: Feruloylated oligosaccharides; DCs: dendritic cells; MAPK:  
mitogen-activated protein kinase; TLR: Toll-like receptor; FA: ferulic acid; APCs:  
antigen-presenting cells; MHC: major histocompatibility complex; BMDCs: bone  
marrow-derived dendritic cells; ERK: extracellular signal-regulated kinase; JNK: c-JUN 
N-terminal kinase; NF-B: nuclear factor kappa-light-chain-enhancer of activated B cells; 
TNF-alpha: tumor necrosis factor; IL: interleukin; TH: T helper cells; IFN-γ: interferon-γ;  
LPS: lipopolysaccharides; LTA: lipoteichoic acid; MFI: mean fluorescence intensity;  
OVA: ovalbumin; MCP-1: monocyte chemotactic protein-1; MIP-1β: macrophage 
inflammatory protein-1 beta; RANTES: regulated on activation; normal T cell expressed 
and secreted. 
1. Introduction 
Ferulic acid (4-hydroxy-3-methoxycinnamic acid; FA) is one of the most abundant, ubiquitous 
hydroxycinnamic acids derived from phytochemical phenolic compounds. In cereals, significant levels 
of FA are in an insoluble bound form, esterified with the arabinose of arabinoxylans in the cell wall [1]. 
Treatment of Gramineae tissues with partial enzymatic or mild acid hydrolysis yielded FOs, which 
were purified with the subsequent chromatographic fractionation. FOs involve various oligosaccharides 
ester-linked to ferulic acid, such as feruloylated disaccharide O-[5-O-(trans-feruloyl)-α-L-Ara f]-
(1→3)-D-Xyl p, and the feruloylated trisaccharide derived from arabinoxylans, O-[5-O-(feruloyl)-α-L-
Ara f]-(1→3)-O-β-D-Xyl p-(1→4)a-D-Xyl p [2,3]. FOs have shown many functional properties, such 
as their antioxidant characteristics and immunostimulatory activity in macrophages, which was proved 
by increasing the production of TNF-α, IL-1β, IL-6, NO and PGE2 in RAW 264.7 [3,4]. These functions 
suggested that FOs might have potential for use in atherosclerosis prevention or in other applications 
where their antioxidant and immunostimulatory capacities would be a valuable asset, such as in the 
health food, pharmaceutical and cosmetic industries. 
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that play the unique role of 
immune sentinels by initiating T cells responses and linking innate and adaptive immunity [5,6]. DCs 
are present at different stages of maturation in the circulation and in nonlymphoid and lymphoid organs. 
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DCs reside in an immature form in peripheral nonlymphoid tissues, where they capture and process 
exogenous antigens [7]. Thereafter, DCs migrate to the T cell areas of the lymphoid organs, where they 
present antigenic peptides to T lymphocytes and stimulate naïve T cell responses through cytokine 
signals, major histocompatibility complex (MHC) molecules and co-stimulatory molecules (e.g., CD40, 
CD80 and CD86) [8]. As key regulatory mediators of immune responses, DCs are being pursued for 
the development of potent new vaccines against cancer and infectious disease [9]. In addition, the 
identification of materials that can modulate DCs activation and function is an emerging field that can 
develop alongside DCs immunobiology [10]. Therefore, natural or synthetic activators that promote 
DCs activation may potentially be candidate adjuvants for application in immunotherapy and vaccination. 
In this research, we aim to investigate the effect of FOs of rice bran on immune response and its 
potential cellular targets. Herein, we evaluate whether FOs affect the maturation and functional properties 
of murine bone marrow-derived dendritic cells (BMDCs). 
2. Results 
2.1. FOs Increase Cytokine and Chemokine Production by BMDCs 
Mature DCs are characterized by the synthesis and secretion of pro-inflammatory cytokines, 
chemokines, and up-regulation of surface co-stimulatory molecules and major histocompatibility 
complex molecules [5–7]. Therefore, in the first series of experiments, we investigated the effect of 
FOs on the secretion of the selective pro-inflammatory cytokines TNF-alpha, IL-6, IL-10 and the Th1 
cytokine IL-12 in the supernatants of BMDCs by sandwich ELISA. BMDCs treated with LPS were 
used as a positive control and PBS as a negative control. The results in Figure 1 indicate that DCs 
treated with FOs dosages of 25 μg/mL or more, significantly increase TNF-alpha, IL-6, IL-10 and IL-12 
production as compared to the control group, in a dose-dependent manner. Similar to FOs, LPS 
significantly enhanced these cytokines compared to the control group. The maximal cytokine levels 
induced by LPS (100 ng/mL) are comparable to the maximal levels induced by 50 μg/mL FOs. There 
is a similar tendency in the production of chemokines induced by FOs. Figure 1 shows that FOs  
(25–100 μg/mL) stimulated DCs to produce substantial amounts of dose-dependent MCP-1, and RANTES. 
2.2. FOs Up-Regulate the Expression of Immunomodulatory Cell Surface Markers on BMDCs 
The maturation status of BMDCs was also indicated by the enhanced expression of surface 
molecules on CD11c+ cells. As shown in Figure 2, FOs (50 μg/mL) stimulation of BMDCs resulted  
in significant up-regulation of co-stimulatory molecules (CD80, CD86 and CD40) and major 
histocompatibility complex molecules (MHC class II and MHC class I) within 24 h compared to the 
control group. The increased MHC class I and MHC class II and CD80/86/40 expression levels provided 
further evidence that FOs promote DC maturation. Taken together, FOs induces phenotypic and functional 
maturation of DCs as evident from an increase in the expression of co-stimulatory molecules and 
MHC, and stimulation of cytokines and chemokines. 
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Figure 1. Cytokine and chemokine production are increased in BMDCs stimulated with 
FOs (12.5–100 g/mL) for 24 h (6 h for the TNF-alpha). The data are presented as the  
mean ± SD from triplicate well measurements from one of three independent experiments 
with similar results. * p < 0.05, ** p < 0.01, *** p < 0.001 was for the comparison between 
FOs-treated and PBS-treated control DCs. 
 
2.3. FOs Increase the Ability of BMDCs to Stimulate OVA-Specific T-cell Proliferation 
It has been reported that fully mature DCs induce higher levels of allogenic T cell proliferation as 
compared to immature DCs [11].To further compare the stimulatory properties of DCs cultured with 
FOs, the effect of FOs on BMDCs-mediated activation of OVA antigen-specific T cell responses was 
examined. FOs-treated, OVA257–264 (OVAP1) or OVA323–339 (OVAP2) peptide-loaded BMDCs were 
co-cultured with their syngeneic OVA-specific CD4+ OT-II or CD8+ OT-I T cells, and T cell proliferation 
was measured by [3H] thymidine incorporation. The results showed that FOs-activated BMDCs 
effectively induced enhanced OVA-specific CD4+ (OT-II) and CD8+ (OT-I) T proliferative responses  
in vitro (Figure 3A). Therefore, the level of IFN-γ in the culture supernatant was also measured using 
ELISA. As shown in Figure 3B, FOs treatment also increased the amount of IFN-γ produced by the 
activated CD4+ and CD8+ T cells. These results revealed that FOs enhance the ability of DCs to induce 
Ag-specific T cell immune responses. 
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Figure 2. FOs up-regulate the expression of co-stimulatory molecules and MHC proteins 
on BMDCs Immature DCs were treated with 50 μg FOs or 100 ng/mL LPS for 24 h. After 
incubation, cells were stained with specific primary antibodies against (A) Co-stimulatory 
molecules CD40, CD80, CD86 or (B) MHC proteins, MHC class I, MHC class II which 
was followed analyzed by flow cytometry. The gray-filled area represents staining with 
specific primary antibody. The open histogram represents staining with isotype control 
group. Data were shown as the mean fluorescence intensity (MFI). The histogram shows 
data from one representative experiment of each group. (C) The bar graphs represent the 
mean ± SD from triplicate well measurements from one of three independent experiments 
with similar results. ** p < 0.01, *** p < 0.001; versus PBS-treated DC group. 
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Figure 3. FOs-treated BMDCs increase T cell activation in response to the specific antigen 
OVA (A) CD8+ T cells and CD4+ T cells were prepared from the spleens of OT-I and  
OT-II mice, respectively. Purified T cells were co-cultured with PBS, LPS (100 ng/mL) or 
50 g/mL FOs-treated DCs pulsed with an OVA peptide at the indicated ratio of DCs: T 
cells for 96 h. Cell proliferation was quantified by [3H]-thymidine incorporation for 18 h. 
(B) Supernatants were collected from cultures after 96 h, and IFN-γ production was 
measured by ELISA. All data represent the mean ± SD from triplicate well measurements 
from one of three independent experiments with similar results. *** p < 0.001; versus  
PBS-treated control groups. 
 
2.4. FOs is Involved with ERK, p38, JNK Kinases, and NF-κB p65 Activation 
MAPKs (ERK, p38 and JNK) and NF-κB are known to be associated with proinflammatory cytokine 
gene expression and play a crucial role in DCs maturation [12,13]. To investigate the molecular mechanism 
underlying the effects of FOs, we sought to study the effect of FOs treatment on the MAPKs and NF-κB 
pathways in BMDCs. BMDCs were stimulated with FOs, and western blotting analysis was performed 
to detect the levels of MAPK-ERK, p38, JNK phosphorylation and NF-κB luciferase reporter gene 
expression and nuclear translocation. As shown in Figure 4A, both FOs and LPS can up-regulate the 
phosphorylation of the MAPKs ERK, p38 and JNK between 30 and 60 min after treatment, whereas the 
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levels of the nonphosphorylated proteins were not affected. To further determine whether FOs increase  
the activation of NF-κB, the results showed that FOs and LPS dose-dependently increase  
NF-κB–dependent luciferase enzyme expression (Figure 4B) and NF-κB p65 nuclear translocation  
(Figure 4C). Since LPS stimulation of TLR-4 signaling activates MAPKs and NF-κB signal pathways 
has been well known, total extracts or nuclear extracts from cells prepared with LPS treatment to serve as a 
positive control. 
Figure 4. FOs induces MAPK phsophorylation and NF-κB activation in BMDCs.  
(A) Immature DCs were treated with 50 g FOs or 100 ng/LPS and whole cell lystes fractions 
were collected at indicated time points. Western blotting was performed to determine the 
phosphorylated or non-phosphorylated ERK, JNK, and p38 using phosphor specific Abs, 
respectively. (B) pERK, pp38, pJNK levels were normalized with total ERK, p38 and JNK 
levels and then compared with the PBS treated control group arranged as one unit. (C) 3 h after 
LPS or FOs treatment, cell lysates were prepared and luciferase activity was measured. Data 
represent NF-κB-luciferase activity normalized per unit (relative light unit per second) of 
extract protein. (D) NF-κB p65 in nuclear extracts as mentioned was performed as 
described in material and methods. p65 levels were normalized with laminin B1 and then 
compared with the PBS treated control group arranged as one unit. 
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Figure 4. Cont.  
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Figure 4. Cont. 
 
The graphs shown represent the mean ± SD from three independent experiments with similar results. ** p < 0.01, 
*** p < 0.001; versus PBS treated control groups. 
Next, to further study the roles of these signaling pathway in FOs-induced DCs maturation, we 
treated DCs with chemical inhibitors against MAPKs and NF-κB. Immature BMDCs were pretreated 
with SB203580 (a specific blocker of p38 MAPK), PD98059 (an inhibitor of the ERK pathway),  
JNK I (an inhibitor of the JNK pathway), or BAY 11-7082 (a specific blocker of NF-κB) for 1h and 
subsequently stimulated with FOs (50 μg/mL) for 24 h. As shown in Figure 5, IL-6 and IL-12 secretion 
(Figure 5A), CD86 (Figure 5B), and MHC class II (Figure 5C) expression induced by FOs was 
significantly decreased by SB203580, JNK I and BAY 11-7082. In addition, PD98059 can decreased 
IL-6 and IL-12 cytokine production, but did not affect the CD86 and MHC class II expression. 
Therefore, these results suggest that FOs induce DCs activation, possibly through activation of the p38 and 
JNK MAPK family members and NF-κB pathways, which potentially explains the activating effect of 
FOs on DC maturation. 
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Figure 5. FOs-induced DC maturation was inhibited by PD98059, SB203580, JNK I, BAY 
11-7082. Immature DCs were pre-treated with PD98058 (10 µM), JNK I (10 µM), 
SB203580 (10 µM), and BAY 11-7082 (10 µM) for 1 h before FOs treatment. (A) IL-12 
cytokine and IL-6 production and (B) CD86 and (C) MHC class II expression were 
measured 24 h later. 
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Figure 5. Cont. 
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Figure 5. Cont. 
 
The gray-filled area represents staining with specific primary antibody. The open histogram represents 
staining with isotype control group. Data were shown as the mean fluorescence intensity (MFI). The histogram 
shows data from one representative experiment of each group. The bar graphs represent the mean ± SD from 
triplicate well measurements from one of three independent experiments with similar results. * p < 0.05,  
** p < 0.01, *** p < 0.001 versus DMSO+ FOs treated groups. 
2.5. BMDCs from TLR 4/2-Deficient Mice do not Respond to FOs Stimulation 
Several saccharide components were reported to induce maturation ofDCs via the TLR-2 and  
TLR-4 [14–16].The TLR-4-deficient (C3H/HeJ) and TLR-2 −/− knockout (C57BL/6 background) 
mouse strains are nonresponsive to LPS and lipoteichoic acid (LTA) due to a point mutation or 
knockout of their TLR-4 or TLR-2 receptor genes, respectively. These mice were used to further 
characterize the function of TLR-4 or TLR-2 in FOs-mediated DCs stimulation. Bone marrow-derived 
DCs from C3H/HeJ or TLR-2 −/− mice and wild-type C3H/HeN or C57BL/6 mice were prepared and 
phenotypically analyzed. As shown in Figure 6, FOs stimulated IL-6 and IL-12 production (Figure 6A), 
CD86 (Figure 6B) and MHC class II expression (Figure 6C) and allogeneic T cellsproliferation  
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(Figure 6D) in wild-type DCs, however, these maturation markers was dramatically reduced in 
BMDCs from both TLR-4-deficient and TLR-2 KO mice. These results show that FOs can induce 
BMDCs activation at least through interaction with TLR-4 and/or TLR-2 molecules. 
Figure 6. FOs induces IL-6, IL-12 expression and CD86 and MHC class II expression 
through a TLR-4 and/or TLR-2-dependent signaling pathway. BMDCs were harvested 
from C3H/HeN, C3H/HeJ (TLR-4-deficient), C57BL/6, or TLR-2 KO mice and stimulated 
with FOs (50 μg/mL), LPS (100 ng/mL) or LTA (1 μg/mL). (A) IL-12 cytokine and IL-6 
production and (B) CD86 (C) MHC class II expression were measured 24 h later. The 
gray-filled area represents staining with specific primary antibody. The open histogram 
represents staining with isotype control group. Data were shown as the mean fluorescence 
intensity (MFI). The histogram shows data from one representative experiment of each 
group. (C) The bar graphs represent the mean ± SD from triplicate well measurements 
from one of three independent experiments with similar results. (D) FOs induces the 
capability of stimulating allogeneic T-cell response in MLR of BMDCs. T cells were 
prepared from the spleens of naïve C3/HeN or C57BL/6 mice. Purified T cells were then 
cocultured with FOs (50 μg/mL), LPS (100 ng/mL) or LTA (1 μg/mL) treated TLR wild 
type or mutant BMDCs at the indicated ratio of DCs: T cells for 96 h. Cell proliferation 
was measured by [3H]-thymidine incorporation for 18 h. * p < 0.05 * p < 0.05, ** p < 0.01, 
*** p < 0.001 for the comparison between stimulated BMDCs from the mutant mice and 
their relevant wild type control group. 
 
Molecules 2014, 19 5338 
 
 
Figure 6. Cont. 
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Figure 6. Cont. 
 
3. Discussion 
In our previous study, we demonstrated the immunostimulatory effect of FOs on macrophages, by 
showing that FOs induce the production of proinflammatory mediators in RAW264.7 [4]. We found 
that FOs (0.1–100 μg/mL) induced TNF-α, IL-1β, IL-6, nitric oxide and PGE2 production in 
unstimulated RAW 264.7 in a dose-dependent manner. However, no investigation has clarified the 
molecular mechanisms responsible for the regulation of DCs in their activation and maturation states 
by FOs. DCs are a crucial cell type that acts at the interface of innate and adaptive immune responses 
and has the unique ability to activate naïve T cells [5–7]. Potent modulation of the activation and 
function of this essential cell type might have potential efficacy against tumor or virus infection or 
represent a candidate-adjuvant approach for application in immunotherapy and vaccination [9]. In this 
study, we confirmed the stimulating effect of FOs isolated from rice bran on DCs. Some phenotypic 
and functional changes were observed to occur in FOs-treated DCs: (1) increased cytokine and 
chemokine production; (2) increased expressions of MHC-I/II and co-stimulatory molecules (CD40 
and CD 80/86); and (3) an increased capacity to induce T cell proliferation. 
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In immune responses, IL-12 plays a central role as a link between the innate and adaptive immune 
systems [17]. This cytokine can polarize the immune system toward a primary T helper cell type 1 
(Th1) response. In this study, we found that FOs can induce IL-12 production in BMDCs (Figure 1). In 
addition, co-culture of FOs –stimulated OVA peptide-pulse BMDCs and OVA-specific T cells can 
significantly increase IFN-γ production (Figure 3), which is a major product of Th1 cells [18]. 
Therefore, these results indicate that FOs-stimulated DCs preferentially promote Th1 immune 
responses. On the other hand, because the Th 1 cells producing IFN-γ have been shown to exert a 
powerful antitumor effect, thus further preclinical studies testing the antitumor effect of FOs is also 
needed to confirm the in vivo study results. 
Several known chemokines induce the migration of DCs and may therefore contribute to their 
recruitment during peripheral immune responses [19]. Our results showed that FOs also can enhance 
chemokine production in DCs and could thereby increase the chemoattraction of immune cells around 
DCs, thus creating an ideal microenvironment for activation of adaptive immunity. 
Our present study showed that FOs induce NF-κB signaling pathways, and result in DCs maturation 
(Figure 4). Because NF-κB binding sites are found in the promoter regions of various proinflammatory 
cytokines, including TNF-alpha, IL-6 and IL-12 [20–22], and of co-stimulatory molecules, such as 
CD40 and CD86 [23], indicating that the NF-κB pathway may be involved in FOs-induced DCs 
activation. In addition, our present study also showed that FOs can increase ERK, p38 and JNK MPAK 
phosphorylation. However, in the specific inhibitor study, SB203580 and JNKI, but not PD98059, 
decreased the CD86 and MHC class II expression by FOs-stimulated DCs (Figure 2C). It has been 
showed that LPS can upregulated all three MAPKs phosphorylation in DCs; however, inhibition of 
ERK1/2 by PD98059 does not affect DCs activation but rather regulates DCs survival. In contrast, 
inhibition of p38 by SB203580 strongly reduces the LPS-induced DCs maturation [24,25]. Thus, we 
suggest that p38 and JNK pathways could be involved in the active effect of FOs-induced DCs 
maturation in this study. However, we cannot exclude the dose of these inhibitor incompletely inhibit 
the phosphorylation of MAPK and NF-κB activity in FOs treated BMDCs. Therefore, in order to 
further confirm the involvement of MAPK or NF-κB pathway by other tools, such as small interfering 
RNAs (siRNAs) or short hairpin RNAs (shRNAs) technology is required. 
As described before, the stimulation of TLRs leads to the activation of NF-κB and several MAPK 
pathways, suggesting that TLRs have or share a common signaling pathway [24,26]. The activation of 
a MAPK pathway subsequently induces gene expression by activating several transcription factors, 
including NF-κB [27]. In addition, some complex carbohydrates, such as LPS and peptidoglycan, were 
recognized by TLR-2 or TLR-4 [28,29]. Therefore, our results suggest that FOs induced DCs maturation at 
least in part via TLR-2 and TLR-4 and resulting in the activation of NF-κB and ERK and JNK MAPK 
pathways, however, all of these possibilities require further study. 
We identified FOs as potential ligands for TLR-4 and TLR-2. Because TLR-4 is one of the major 
components of the receptor for LPS to promote DCs activation [30], the possibility of contamination 
with the endotoxin LPS in the FOs preparations used in this study required examination. LAL assays 
showed an endotoxin content of <0.1 ng/mL in our 1 mg/mL FOs stock solutions, resulting in a 
maximum possible contamination throughout the assays of 0.01 ng/mL in the 100 μg/mL concentration  
of FOs. Our previous study showed that DCs failed to mature in response to LPS concentrations  
of <0.1 ng/mL [31]. Furthermore, in blocking experiments for LPS, BMDCs were incubated with  
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10 μg/mL of the LPS inhibitor polymyxin B (PMB) prior to FOs stimulation. PMB did not 
significantly affect the FOs-induced IL-6 and IL-12 production but significantly inhibited the LPS 
effect in the same experiment (Supplemental Figure 1). Collectively, these data suggest that binding of 
FOs to TLR-4 and/or TLR-2 could effectively induce the significant activation and maturation of DCs. 
4. Experimental 
4.1. Mice and Cell Cultures 
Five to eight-week-old specific pathogen-free female C57BL/6, C3H/HeN and C3H/HeJ (TLR-4 
mutant) mice were purchased from the National Laboratory Animal Center (Taipei, Taiwan). TLR-2 
knockout mice were provided by Dr. Chih-Peng Chang (NCKU, Tainan, Taiwan). OT-I TCR 
transgenic mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). OT-II TCR 
transgenic mice were provided by Dr. Clifford Lowell (UCSF, San Francisco, CA, USA).  
NF-B/luciferase transgenic mice which carry the luciferase gene under the control of NF-B were 
provided by Dr. Chuan-Mu Chen. All mice were housed in the barrier facility at Taichung Veterans 
General Hospital (Taichung, Taiwan) in accordance with the Institutional Animal Care and Use 
Committee guidelines for animal experimentation, and all procedures were performed in accordance 
with the Institutional Animal Care and Use Committee guidelines for animal experimentation. Mouse 
DCs were generated from bone marrow as previously described [32]. Bone marrow (BM) cells were 
flushed from the femurs and tibias of mice and pooled from two to three mice per strain for each 
experiment. Red blood cells were lyzed with ammonium chloride, and then washed with PBS. BM 
cells were suspended in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine 
serum, 100 U/mL penicillin G, 100 µg/mL streptomycin, 2 mM L-glutamine, 20 ng/mL recombinant 
mouse granulocyte-monocyte colony-stimulating factor (Peprotech, Rocky Hill, NJ, USA) and 20 ng/mL 
recombinant mouse IL-4 (Peprotech) and cultured in 24-well plates (5 × 105 cells/mL). Fresh medium 
was supplied every 2 days and non-adherent cells were harvested on day 7 as immature DCs. 
4.2. Feruloylated Oligosaccharides 
FOs are obtained from rice bran treated with HCl hydrolysis, according to the previous method with 
modification [33]. Weighed rice bran (1 g) was treated with 20 mL 200 mM HCl at 100 °C for 1 h. 
After centrifugation, the supernatant was filtered and applied to an open column packed with Amberlite 
XAD-2 (previously washed with 95% v/v ethanol and then water). Elution was successively carried out 
with two column volumes of distilled water, three column volumes of 50% v/v methanol and two 
column volumes of methanol. The fraction eluted by methanol/water was concentrated and lyophilized 
to get the dry FOs for further analysis. The yield was 0.0358g/g rice bran. The acryl ferulic group was 
released by mild alkaline treatment of FOs. FOs (100 μL, 1 mg/mL) were hydrolysed with NaOH (100 μL, 
0.4 mol/L) for 2 h in the dark at room temperature. The reaction was stopped by adding H3PO4 (150 μL, 
0.4 mol/L). This solution was analysed for ferulic acid by HPLC (Shimadzu LC-10AD, Kyoto, Japan) 
using a C-18 column (5 μm, 4.6 mm × 250 mm, Mightysil RP-18 GP, Kanto Chemicals, Tokyo, 
Japan). The column was maintained at 30 C. A sample volume of 10 μL was injected into the column 
and eluted with methanol/water/acetic acid (50:50:0.5, v/v/v) at a flow rate of 0.8 mL/min for 15 min. 
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The absorbance of the eluate was monitored continuously at 320 nm. Ferulic acid released from FOs 
was identified by comparison of its relative retention time with a ferulic acid standard. The result 
showed that the quantity of the acyl ferulic group in FOs was about 15.31 mg/g FO (~548 μg/g of rice 
bran). To remove endotoxins (lipopolysaccharides or LPS), the sample preparations were passed 
through an EndoTrap Blue column (Hyglos, Bernried, Germany). The endotoxin activity in the sample 
preparation was determined by a quantitative, chromogenic QCL-1000 Limulus amoebocyte lysate 
(LAL) assay (Cambrex Bio Science Walkersville, Inc., Walkersville, MD, USA) according to the 
manufacturer’s protocol and was found to be <0.1 ng/mg FOs. 
4.3. In Vitro dcs Activation 
Immature DCs were cultured at a density of 1 × 106 cells/well in 24-well plates in medium alone or  
in the presence of 100 ng/mL LPS (Escherichia coli, serotype O26:B6, Sigma St. Louis, MO, USA),  
1 μg/mL lipoteichoic acid (LTA; L2515, from Staphylococcus aureus, Sigma) or FOs  
(6.25–100 μg/mL) for 24 h (or 6 h for the TNF-alpha ELISA). The cells were then used for  
further immunophenotyping, the cytokine production assay or the addition of T cells for DCs-T  
co-culture experiments.  
4.4. Flow Cytometric Analysis of Surface Markers 
After stimulation, DCs were harvested and stained with FITC-conjugated mouse CD11c+ (clone 
N418) or phycoerythrin (PE)-conjugated anti-mouse CD40 (clone 3/23), anti-mouse CD80 (clone  
16-10A1), anti-mouse CD86 (clone GL1), anti-mouse MHC class I (clone AF6-88.5), anti-mouse 
MHC class II (clone M5/114.15.2) or isotype-matched control mAbs (clone MOPC-173), all from 
Biolegend, San Diego, CA, USA, for 45 min on ice (1 μg/mL diluted in PBS/1.0% FCS(v/v)). After 
washing with PBS, the fluorescence intensity was measured with a FACSCalibur flow cytometer (BD 
Biosciences, Heidelberg, Germany), and the data were analyzed using WINMDI software (Scripps, La 
Jolla, CA, USA). The results are expressed in terms of the relative mean fluorescence intensity (MFI) 
on CD11c+ gated DCs. 
4.5. Cytokine Detection 
To quantify the production of cytokines and chemokines, supernatants were collected from immature 
DCs propagated in the presence ofLPS or FOs. After incubation, cytokines (mTNF-alpha, mIL-6, and 
mIL-12, mIL-10) production and chemokines (MIP-1 alpha and RANTES) by DCs were measured in 
the supernatants by sandwich ELISA assays according to the manufacturer’s specifications (all from 
PeproTech, Rocky Hill, NJ, USA). 
4.6. Neutralization Experiments 
BMDCs were preincubated with 10 μM SB203580 (a specific blocker of p38 MAPK, Sigma-Aldrich, 
St Louis, MO, USA), 10 μM PD98059 (an inhibitor of the ERK pathway, Sigma-Aldrich), 10 μM JNK 
I (an inhibitor of the JNK pathway, Calbiochem, San Diego, CA,USA), or 10 μM BAY 11-7082  
(a specific blocker of NF-κB, sigma) for 1 h followed by FOs (50 μg/mL) treatments for 24 h. The 
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conditioned media were collected and analyzed for IL-6 and IL-12 secretion by ELISA. The cells were 
harvested and analyzed surface marker CD86 and MHC class II expression by flow cytometry. The 
doses of these inhibitors are referred to previous reports [25,34]. Furthermore, in blocking experiments 
for LPS were also according to previous reports [35,36]. In brief, BMDCs were incubated with  
10 μg/mL of the LPS inhibitor polymyxin B (PMB) prior to FOs stimulation. 
4.7. OVA-Specific T Cell Activation 
Immature DCs from C57BL/6 mice were pulsed with 2 μg/mL OVA257–264 (OVAP1) or  
OVA323–339 (OVAP2) (synthesized by Echo Chemical Co., Miaoli, Taiwan) in the presence of LPS or  
FOs (50 μg/mL) for 24 h. FOs were then washed out, and OVAP1-specific CD8+ T cells(2 × 105) and 
OVAP2—specific CD4+ T cells (2 × 105) were added to the culture at 1:5 DCs:T cell ratio in 96-well 
round-bottom plates. The OVA-specific CD4+ and CD8+ T cells were positively enriched from the 
pooled spleens of two to three OT-1 and OT-2 mice by EasySep® Mouse CD8a Positive Selection Kit 
separation and EasySep® Mouse CD4 Positive Selection Kit separation, respectively, according to the 
manufacturer’s protocol (Stem Cell Technologies, Grenoble, France). After an additional 96 h of  
co-incubation, T cell proliferation was measured by adding 1 μCi of [3H] thymidine (GE Healthcare, 
Buckinghamshire, UK) for overnight incubation; quantification of incorporated [3H] thymidine was 
subsequently performed by liquid scintillation counting on a β-Counter (Beckman Instruments, Palo Alto, 
CA, USA) [32]. In addition, the IFN-γ ELISA kit (eBioscience, San Diego, CA, USA) was also used 
following the manufacturer’s protocol. 
4.8. Allogenic Mixed Lymphocyte Reaction 
Mouse T cells were isolated from naïve C57BL/6, C3/HeNmice spleens using EasySep Mouse T 
Cell Enrichment Kit separation, respectively, according to the manufacturer’s protocol (Stem Cell 
Technologies). Immature BMDCs were generated from C57BL/6, C3H/HeN, C3H/HeJ and TLR-2 KO 
mice and then stimulated with LPS (100 ng/mL), LTA (1 μg/mL) or FOs (50 μg/mL) for 24 h. After 
stimulation the cells were harvested, washed, and diluted with the prepared enriched T cells (2 × 105) 
in ratios of 10:1, 5:1 and 1:1 (T cells: DC) in 96-well round-bottom plates (Corning, NY, USA). After 
an additional 96 h of co-incubation, T cell proliferation was measured by adding 1 μCi of [3H] 
thymidine (GE Healthcare) for overnight incubation; quantification of incorporated [3H] thymidine 
was subsequently performed by liquid scintillation counting on a β-Counter (Beckman Instruments, 
Palo Alto, CA, USA). 
4.9. Activity Assay for MAPKs and NF-κB 
Immature DCs were stimulated with 50 μg/mL FOs, and whole cell lysates and nuclearfraction 
extracts were prepared at the indicated time points as previously described [33]. The protease inhibitors 
leupeptin (Sigma-Aldrich) and aprotinin (Sigma-Aldrich) were used at a concentration of 10 μg/mL in 
all steps. Protein concentrations were determined using a BCA protein assay kit (Pierce, Rockford, IL, 
USA) prior to western blot or other protein analysis. For protein detection, protein extracts (40 g/mL) 
were boiled separated on 10% SDS-polyacrylamide gels and electrotransferred to nitrocellulose 
Molecules 2014, 19 5344 
 
 
membranes. The membranes were blocked for 1 h with 5% skim milk in TBS + 0.05% Tween 20. 
After blocking, the membranes were incubated overnight with the suggested concentrations of either a 
primary antibody against phospho-p38, p38, phospho-p42/44, total p42/44, phospho-JNK, NF-B p65, 
Lamin B1, β-Actin (all purchased from Cell Signaling Technology, Beverly, MA, USA). The membranes 
were washed prior to incubation with HRP-Conjugated Goat Anti-Mouse IgG (115-035-068) or HRP-
Conjugated Goat Anti-Rabbit IgG secondary Abs (111-035-003) (all purchased from Jackson 
ImmunoResearch, West Grove, PA, USA). The proteins were detected by enhanced chemiluminescence 
(GE Healthcare) and analyzed using the LAS3000 system (Fujifilm, Tokyo, Japan). Densitometric 
analysis was performed with ImageJ software (National Institute of Health, Bethesda, MD, USA). 
Active forms of MAPKs (pERK, p38 and pJNK) were normalized with corresponding total 
nonphosphorylated forms. To examine the NF-κB transcriptional activity, the Bone marrow derived 
DCs were generated from NF-B-luciferase transgenic mice as above described. Cell were incubated 
with 100 ng/mL LPS or 50 µg/mLFOs  for 3 h. Cell extracts were prepared using luciferase cell lysis 
buffer (Promega, Madison, WI, USA ) and mix 20 µL cell extracts with 100 µL of luciferase assay 
reagent (Promega). Then, the lucifease activity was counted for 10 s in a Turner BioSystems 
luminometer (Promega, Sunnyvale, CA, USA) and results were normalized per unit (relative light unit 
per second) of extract protein.  
4.10. Statistical Analysis 
All statistical analyses were performed using the GraphPad Prism software package version 4.0. 
The statistical analyses of cytokine production, surface marker expression, T cell proliferation and 
western blotting and luciferase assay were performed using one-way ANOVA followed by Tukey’s 
post-hoc test. A p < 0.05 was considered statistically significant. 
5. Conclusions 
In summary, for the first time, we present evidence demonstrating that FOs of rice bran can 
augment DCs maturation in an in vitro culture system. However, we also believe that additional issues 
warrant future investigation. In particular, the details of the molecular mechanisms underlying the 
ability of FOs to induce DCs function are poorly understood that remains to be determined. In 
addition, although our results showed that FOs enhances DCs function in vitro, it remains unknown 
how this is effective under in oral administration in animals. 
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